A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid‐targeted bromodomain and extra‐terminal domain inhibitor
Brown, Jack A., Bal, Joanne, Simeoni, Monica, Williams, Peter, Mander, Palwinder K., Soden, Peter E., Daga, Shruti, Fahy, William A., Wong, Gabriel K., Bloomer, Jackie C., Erwig, Lars, Cui, Yi, Fernando, Disala, Carnaghan, Helen, Banham‐Hall, Edward J., Hopkins, Sarah, Davis, Bill G., Oliveira, Joao J. D., Prinjha, Rabinder K.
Published in British journal of clinical pharmacology (01.05.2022)
Published in British journal of clinical pharmacology (01.05.2022)
Get full text
Journal Article
Ofatumumab, a Human Mab Targeting a Membrane-Proximal Small-Loop Epitope On CD20, Induces Potent NK Cell-Mediated ADCC
Craigen, Jenny L, Mackus, Wendy J.M., Engleberts, Patrick, Miller, Sam R, Speller, Sue, Chamberlain, Louise C, Davis, Bill G, McHugh, Simon M, Bullmore, Ed, Cox, Charles J, Wetten, Sally, Perdock, Gerrard, Bakker, Joost M, van de Winkel, Jan G.J., Parren, Paul W. H.I.
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article